Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of ZaStaprazan on Platelet Reactivity of Clopidogrel After PCI (EZ-STAR)
KCT0011466Phase 4Not yet recruiting
- Sponsor
- Jeil Pharmaceutical Co., Ltd.
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Chronic Coronary Syndrome (CCS) comparing ZaStaprazan + clopidogrel with Placebo + clopidogrel (2 arms). Planned start Mar 2026; status: not yet recruiting.
02
Drugs
zastaprazan
03
Conditions
Chronic Coronary Syndrome (CCS)
Beyond the preview
Go deeper on KCT0011466.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0011466.